Valeant vows to improve Allergan merger offer

13 May 2014 - Deborah Wilkes

Archived

Valeant Pharmaceuticals International plans to "improve" its merger proposal to Allergan after the board of the Botox maker "unanimously rejected the unsolicited proposal".

Click tags below for more information on topics:

Bausch Health

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: